Previous studies revealed an association of EMT with cancer onset and invasiveness in MPM [70] leading to in vitro experiments and preclinical trials using EMT-targeting drugs and TGFβ inhibitors showed promising results in these studies [71]. Here, TGFB1 is linked to cancer.